Loading…

Protocol - Current Contraception Use - Male

Add to My Toolkit
Description:

Male participants are asked about contraception use in the last 12 months.

Protocol:

1. Including any methods you may have already told me about and methods you may have used only once, during the last 12 months, which of these methods did you and she use to prevent pregnancy or sexually transmitted diseases?

ENTER all that apply.

[ ] 1 Condom or rubber

[ ] 2 Withdrawal or pulling out

[ ] 3 Vasectomy or male sterilization

[ ] 4 Pill

[ ] 5 Tubal ligation or female sterilization

[ ] 6 Injection (Depo-Provera® or Lunelle*)

[ ] 7 Spermicidal foam/jelly/cream/film/suppository

[ ] 8 Hormonal implant (Norplant®, Implanon ™, or Nexplanon ™)

[ ] 9 Rhythm or safe period

[ ] 10 Contraceptive patch (Ortho-Evra™)

[ ] 11 Vaginal contraceptive ring (Nuva Ring™)

[ ] 12 IUD, coil, loop

[ ] 13 Something else

*Lunelle is no longer available in the U.S.

Depo-Provera® is a registered trademark of Pfizer Inc.; Norplant® is the registered trademark of the Population Council for levonorgestrel-releasing capsule implants for protection against pregnancy; Ortho-Evra™ is the registered trademark of Johnson & Johnson, Iplanon™ is the registered trademark of the MERCK SHARP & DOHME B.V, Nexplanon™ is the registered trademark of the MERCK SHARP & DOHME B.V, NuvaRing® is a registered trademark of N.V. Organon Corporation (Netherlands).

Protocol Name from Source:

National Survey of Family Growth (NSFG)

Availability:

Publicly available

Personnel and Training Required

None

Equipment Needs

If a computer-assisted instrument is used, computer software may be necessary to develop the instrument. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Interviewer-administered questionnaire

Life Stage:

Adolescent, Adult

Participants:

Males 15-44 years of age.

Specific Instructions:

The National Survey of Family Growth (NSFG) provides a card of response categories to the respondent. For example, in question 1 for males, an investigator would provide the respondent with a card listing the categories in question 1.

Selection Rationale

This approach, which has been utilized in several national surveys, provides for minimal burden, as it does not require extensive questioning. It is adaptable to both men and women.

Language

English

Standards
StandardNameIDSource
Common Data Elements (CDE) Male Current Contraception Use Assessment Description Text 5719178 CDE Browser
Process and Review

The Expert Review Panel #5 (ERP 5) reviewed the measures in the Reproductive Health domain.

Guidance from ERP 5 includes the following:

· Updated protocol

· New Data Dictionary

Back-compatible: there are changes to the Data Dictionary, previous version of the Data Dictionary and Variable mapping in Toolkit archive (link)

Source

National Survey of Family Growth (NSFG) 2013-2015 Male. NSFG CWPALLBC (CF-2).

General References

Lepkowski, J. M., Mosher, W. D., Davis, K. E., Groves, R. M., van Hoewyk, J., & Willem, J. (2006). National Survey of Family Growth, Cycle 6: Sample design, weighting, imputation, and variance estimation. Vital Health Statistics, 2(142), 1-82.

Martinez, G. M., Chandra, A., Abma, J. C., Jones, J., & Mosher, W. D. (2006). Fertility, contraception, and fatherhood: Data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital Health Statistics, 23(26), 1-142.

Protocol ID:

100304

Variables:
Export Variables
Variable NameVariable IDVariable DescriptionVersiondbGaP Mapping
Research Domain Information
Measure Name:

Current Contraception Use

Release Date:

April 11, 2017

Definition

Questions to assess participants’ use of contraception.

Purpose

The purpose of these questions is to determine the type of contraceptive methods used by both female and male study participants. Certain methods, such as hormonal contraceptives, may be associated with gene/environment factors. Contraceptive methods might also be of interest as they relate to risk of sexually transmitted diseases.

Keywords

Reproductive health, contraceptive methods, birth control, National Survey of Family Growth, NSFG